New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Psyence Biomedical Ltd.

PBM

Healthcare Biotechnology

2.97 0.11 +3.85%

After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.

Market cap
$10.9M
P/E
0.1×
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
1.2×
Payout ratio
—

What it owns vs. what it owes End of fiscal 2026, Mar 31, 2026

Shareholders’ equity is 96.5% of the balance sheet. What is a balance sheet?

Mar 31, 2026 · total $17.6M

Owns

$6.0KLong-term assets
$1.6MOther short-term assets
$15.9MCash & all investments

Funded by

$16.9MShareholders’ equity
$623.2KOther liabilities

Debt is 0.00% of the total; shareholders’ equity 96.5%.

Jan '21 Jan '22 Dec '23 Mar '24 Mar '25 Mar '26
Total current assets
0.97 1.21 1.13 1.13 6.56 9.11
Total non-current assets
— — 0.01 0.01 0.76 8.46
Total Assets
256.22 258.93 1.13 1.13 7.32 17.57
Total current liabilities
0.07 14.27 12.10 12.10 0.59 0.62
Total liabilities
19.58 14.27 12.10 12.10 0.59 0.62
Common Equity (Total)
236.65 244.66 (57.46) (10.97) 6.72 16.94
Shareholders Equity (Total)
236.65 244.66 (10.97) (10.97) 6.72 16.94
Other line items

Show all line items

In millions of $ except per-share values · columns are period end dates